Hong Kong/China M&A/Events

Hong Kong/China M&A/Events

China Travel (308 HK): Hard To Get Excited With The In-Specie. Or The Rump

Quiddity Research's avatar
Quiddity Research
Nov 05, 2026
∙ Paid
  • On the 20th May 2026, China Travel (308 HK) announced the proposed spin-off, via an in-specie distribution, of HKM Culture and Tourism on the HKEx. The market response was largely “meh”.

  • HKM Culture and Tourism covers visa documentation, cross-border transportation, and hotels (HK, Macau & Beijing). The rump comprises scenic destinations, theme parks, and select integrated destination resorts.

  • The record date for the in-specie distribution is the 20th November. I’m not convinced I’d want to own either stock.

China Travel International Investment Hong Kong (308 HK) is illiquid. Look away now if this is not your bag


Conclusions First

  • HKM is touted as representing stable, high-margin, asset-light services, versus China Travel’s large-scale, asset-heavy scenic spots and theme parks in China.

  • HKM is at least profitable. Stable - yes. But no growth. Contracting if anything.

  • On balance, I tilt towards HKM over China Travel, as it appears easier to value versus China Travel’s rump.

  • Yet HKM numbers - full-year and interim - don’t scream “you need to get exposure”.

  • China Travel’s ~3% decline in share price since making the April 2026 spin-off announcement is illustrative.

Keep reading with a 7-day free trial

Subscribe to Hong Kong/China M&A/Events to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2026 Quiddity Investment Advisors · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture